Ligand validation:6GA7

C14: TETRADECANE

C14 is a Ligand Of Interest in 6GA7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GA7_C14_A_313	35%	76%	0.181	0.87	0.1	0.82	-	-	0	0	100%	1
6GAA_C14_A_313	37%	76%	0.166	0.861	0.1	0.82	-	-	0	0	100%	1
6GA6_C14_A_313	33%	77%	0.168	0.845	0.1	0.81	-	-	1	0	100%	1
6GAB_C14_A_313	32%	76%	0.175	0.849	0.1	0.82	-	-	1	0	100%	1
6GA9_C14_A_313	32%	76%	0.177	0.851	0.1	0.82	-	-	0	0	100%	1
6GA8_C14_A_313	29%	76%	0.184	0.839	0.1	0.82	-	-	0	0	100%	1
6LM1_C14_B_320	57%	70%	0.112	0.885	0.29	0.85	-	-	0	0	100%	1
7PZF_C14_B_404	50%	87%	0.113	0.914	0.26	0.44	-	-	0	0	71%	0.7143
6ZOC_C14_C_1103	48%	100%	0.169	0.911	0.08	0.08	-	-	0	0	100%	1
7OUK_C14_C_1706	42%	100%	0.182	0.901	0.08	0.05	-	-	0	0	100%	1
6LM0_C14_B_305	42%	70%	0.201	0.92	0.29	0.85	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.